• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS VORTEX CT PORT ACCESS SYSTEM; SMARTPORT CT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS VORTEX CT PORT ACCESS SYSTEM; SMARTPORT CT Back to Search Results
Catalog Number H787CT80STPD0
Device Problems Leak/Splash (1354); Device Issue (2379)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/13/2017
Event Type  Injury  
Manufacturer Narrative
It was reported that the device involved in the incident is available to be returned to the manufacturer for evaluation.To date the device has yet to be returned.Attempts are being made to obtain the device.An investigation into the root cause for incident is currently in progress.The results of the investigation will be sent via a follow up medwatch.(b)(4) : device not returned to date.
 
Event Description
As reported on (b)(6) 2017: the implanted port was noted to leak injection contrast when injected.There was no report of permanent patient harm or injury.It was reported defective device is available for return to the manufacturer for a device evaluation.
 
Manufacturer Narrative
Returned for evaluation was one port and catheter tubing attached.As received the catheter was trimmed to approximately 24 cm and was attached to the port.There was a small gap between the blue boot and the port body with some bio matter in this gap.Leak testing was performed with air at 40 psi through septum with distal tip of catheter clamped, no decay (.00 psi in 7 seconds) was detected.The device met all manufacturing dimensional specifications.The customer's complaint description of leak during injection could not be confirmed.No manufacturing non-conformance were observed during sample evaluation and the catheter tubing met dimensional specifications.No manufacturing related or any other defects were noted during the evaluation.A definitive root cause could be determined.The end user attaches the catheter tubing and blue boot to the port during the implantation procedure.A device history report review of the affected lots revealed no quality related issues or manufacturing deficiencies at the time of manufacture.The instructions for use, which is supplied to the user with this catalog number, contains the following statements: caution: it is extremely important to adequately flush the port after blood withdrawal.Occlusion of the catheter can occur if blood is left in the catheter for an extended period of time.Power injection should not be performed if blood aspiration is not present or the port is difficult to flush.If the implanted port is utilized, it may result in device failure or patient injury.Two-way obstruction (unable to infuse through the port system and unable to aspirate blood): causes: a fibrin tail, clot or sheath may be on or within the catheter.The non-coring (huber point) needle may not be patent or properly positioned within the port septum.Confirm that the needle is of sufficient length and, when positioned in the septum, the needle opening is not occluded by the septum.The clamp on the non-coring (huber point) needle should be open.A drug precipitate caused by incompatible drugs infused through the port may be obstructing the system.To prevent, use adequate amounts of sterile normal saline between incompatible solutions.A thrombolytic agent may be used on the order of a physician to restore patency.The procedure should be outlined by the drug manufacturer's labeling.Use facility protocol to determine which thrombolytic agent to use.The use of streptokinase has been known to cause allergic and anaphylactogenic reactions.A contrast study performed through the port may confirm fibrin sheath presence, kinking, malposition, or pinch-off syndrome.Caution: do not force solutions through the port system to clear an obstruction.A high pressure situation may cause irreversible catheter damage, leading to port system explant.Pinch-off syndrome: pinch-off syndrome signs may include difficulty in aspirating blood, resistance to flushing or infusion of medications or fluids that improves with position changes, infraclavicular pain and/or swelling with catheter flushing or infusion palpitations, sudden onset chest pain, cardiac arrhythmias, extra heart sound, chest wall swelling at the port pocket, vein insertion site, pain in shoulder or port area not associated with swelling, cough, paresthesia of arm on side of catheter withdrawal occlusion or swishing sound with catheter flushing.Warning: avoid medial catheter placement into subclavian vein through percutaneous technique.This placement could lead to catheter occlusion, damage, rupture, shearing, or fragmentation due to compression of the catheter between the first rib and clavicle.Catheter shearing has been reported when the catheter is inserted via a more medial route in the subclavian vein.1.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Complaint reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VORTEX CT PORT ACCESS SYSTEM
Type of Device
SMARTPORT CT
Manufacturer (Section D)
ANGIODYNAMICS
one horizon way
manchester GA 31816
Manufacturer (Section G)
ANGIODYNAMICS
one horizon way
manchester GA 31816
Manufacturer Contact
law ryan
10 glens falls technical park
glens falls, NY 12801
5187424488
MDR Report Key6325279
MDR Text Key67228367
Report Number1056436-2017-00011
Device Sequence Number1
Product Code LJS
UDI-Device IdentifierH787CT80STPD0
UDI-PublicH787CT80STPD0
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date09/30/2019
Device Catalogue NumberH787CT80STPD0
Device Lot Number5083686
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/10/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/28/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-